Genenta Science S.p.A.
GNTA · NASDAQ
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $48,568 | $76,833 | $52,394 | $81,576 |
| - Cash | $5,177 | $4,582 | $6,188 | $3,691 |
| + Debt | $7,555 | $15 | $21 | $0 |
| Enterprise Value | $50,946 | $72,265 | $46,227 | $77,885 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | -$42 |
| % Margin | – | – | – | – |
| EBITDA | -$3,369 | -$5,224 | -$4,496 | -$4,911 |
| % Margin | – | – | – | – |
| Net Income | -$3,827 | -$4,874 | -$4,039 | -$4,886 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.2 | -0.27 | -0.22 | -0.27 |
| % Growth | 25.9% | -22.7% | 18.5% | – |
| Operating Cash Flow | -$6 | -$6,238 | -$2 | -$4 |
| Capital Expenditures | -$0 | -$4 | $0 | $0 |
| Free Cash Flow | -$6 | -$6,243 | -$2 | -$4 |